Delaware BioScience Association

Organizer

Delaware BioScience Association
Phone
302-635-0445
Email
[email protected]
Website
https://delawarebio.org/
REGISTER

Speakers

  • Benjamin Quang Duong PharmD
    Benjamin Quang Duong PharmD
    Clinical Pharmacogenomics Service Manager

    Dr. Benjamin Duong is the Clinical Pharmacogenomics Service Manager under the Nemours Precision Medicine Program at Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. He leads the implementation of a pharmacogenomics service across the Nemours Children Health System enterprise with hospitals and clinics in Delaware, Florida, Maryland, Pennsylvania, and New Jersey. He received his Doctorate of Pharmacy in 2016 and completed a Clinical Pharmacogenomics pharmacy residency in 2018 from the University Of Florida College Of Pharmacy in Gainesville, FL. His focus includes implementation of a pharmacogenetic testing service that will improve the wellbeing of pediatric patients through increased pharmacotherapy clinical effectiveness while minimizing adverse drug reactions associated with genetic variants. His implementation of pharmacogenomics includes developing pharmacogenetic tests, integrating pharmacogenetic clinical decision support into the electronic medical records, providing clinical recommendations with internal and external pharmacogenomic results, and educating patients and health care professionals.

  • Katherine Robbins Ph.D.
    Katherine Robbins Ph.D.
    Director, Nemours Biomolecular Core Lab

    Dr. Katherine Robbins is the director of the Nemours Biomolecular Core Laboratory, that provides essential services in molecular biology and genetics to the clinical and research staff at Nemours, Delaware INBRE partner institutions, and external clients. The Biomolecular Core Laboratory provides consultation on experimental design as well as data troubleshooting, training, and mentoring of students and clinical fellows. The BCL is also a collaborative research laboratory focusing on the study of rare pediatric genetic disorders. She received her doctorate in Biological Sciences from University of Delaware in 2016 and her continued interest is primarily associated with rasopathies, skeletal dysplasias and cancer. In addition, she is Assistant research scientist in the Nemours Molecular Diagnostics Laboratory, where she helps implement new diagnostic testing and assays. She works closely in a team-science based approach with clinicians, pharmacists, researchers, patient and family groups to bring the necessary testing needed to Nemours. Most recently, the Molecular Diagnostics and Biomolecular Core labs have worked closely with Dr. Benjamin Duong, PharmD Clinical Pharmacogenomics Service Manager, and the Nemours Precision Medicine Program to develop a pharmacogenomics 10 gene assay that has been implemented in both clinical and research settings at Nemours.

Location

Virtual
QR Code

Date

Jul 23 2020

Time

8:30 am - 10:30 am

July 2020 BioBreakfast

VIRTUAL BIOBREAKFAST

Although live events aren’t possible right now, our connectivity and collaboration go on! Delaware Bio’s BioBreakfast will be virtual in July 2020! Join us to experience the same great BioBreakfast event in a virtual setting.

Join us virtually on Thursday, July 23rd from 8:30 – 10:30 am as we hear from Benjamin Quang Duong, PharmD, Clinical Pharmacogenomics Service Manager and Katherine M. Robbins, Ph.D., Director of Nemours Biomolecular Core Lab as they discuss the rollout of the Clinical Pharmacogenomics Service at Nemours/Alfred I. duPont Hospital for Children and explain the collaboration between the Precision Medicine program, Molecular Diagnostic Laboratory, and Biomolecular Core Laboratory in the development and integration of a customized PGx panel with copy number assays into the electronic health record. 

Members will also hear from Bob Dearth, Regional Business Development Manager at Biotechnology Innovation Organization (BIO) as he provides an overview of the BIO Business Solutions Program. He will be joined by Stephen Joseph of BREX, Lori Cotsack of Clean Harbors, and Brian Haigh and Jake Rubritz of VWR, Part of Avantor, to help guide members to make sure they are getting the most out of the membership benefits.

We highly recommend that attendees take advantage of the opportunity to join the conversation in the Nemours and BIO Business Solutions Networking sessions.

WHAT IS BIOBREAKFAST

BioBreakfast is Delaware Bio’s signature bi-monthly morning opportunity to connect with the bioscience and life science industry to learn about the industry’s hot topics. This event provides great forums to network with more than 100 professionals from the region over breakfast and coffee and learn about ground-breaking research and news from key members of the life sciences community.

WHY YOU SHOULD ATTEND

  • Hear from and meet with executives at the top life science companies making a difference here in Delaware
  • Connect with new business opportunities
  • Get the pulse on the latest life sciences trends
  • Network with peers and potential partners

EVENT PRICING

Member | FREE

Non-Member | $50

In-Transition | $25

EVENT SPONSORS

         

DELAWARE BIO EVENT POLICIES

Registration Policy

The “In Transition” rate is available for first-time attendees seeking employment. If you are still searching for employment after the first BioBreakfast and wish to continue attending, we offer you a discounted rate of $25 to attend. The “Non-Member” rate is for those who very occasionally attend our events (no more than two events) or for those who are evaluating whether they wish to join Delaware Bio. This is not intended for individuals who attend every event in a series. If you fall into this category, we ask that you join the organization. Information about membership can be found by contacting us at [email protected].

Please note that Delaware Bio is a member-supported organization, preference is given to our members.  If an event becomes sold out and you are registered as a non-member, we reserve the right to cancel your registration and refund your payment. If you are retired and wish to attend BioBreakfast, we ask that you join the organization as a member, at our new, discounted retired membership level.

When registering please use your company email address, so we can verify membership (if applicable). Registration for our virtual events will end 24-hours before the event is set to begin to ensure you receive the proper communication to join the event. Please register in advance, as it may fill up quickly. Thank you!

Refund Policy

Cancellations must be made in writing, via email to Yvette Murray more than one (1) week prior to the event to receive a refund minus 25% for registration/administrative costs. If the cancellation is made within one week of the event or the attendee is a no-show, Delaware Bio will not issue a refund. If you have any questions or concerns, please contact Yvette Murray.

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Hourly Schedule

Event Agenda

8:30 - 8:45
Opening Remarks
Speakers:
Michael Fleming
8:45 - 9:10
Nemours/Alfred I. duPont Hospital for Children
8:45 - 9:10 | Implementation of a Clinical Pharmacogenomic Service and Testing across a Multi-State Pediatric Health System
Speakers:
Benjamin Quang Duong PharmD, Katherine Robbins Ph.D.
9:12 - 9:15
Member Announcement
Potter Anderson Corroon
Speakers:
Janet Reed Ph.D.
9:15 - 9:20
Member Benefit Highlight
BIO Business Solutions Program
Speakers:
Bob Dearth
9:20 - 9:25
BREX
BIO Business Solutions Program Benefits
Speakers:
Stephen Joseph
9:25 - 9:30
Clean Harbors
BIO Business Solutions Program Benefits
Speakers:
Lori Cotsack
9:30 - 9:35
VWR, Part of Avantor
BIO Business Solutions Program Benefits
Speakers:
Brian Haigh, Jake Rubritz
9:35 - 9:40
Closing Remarks
Speakers:
Michael Fleming
9:45 - 10:30
Networking Breakout Session
Nemours Networking Session
Speakers:
Benjamin Quang Duong PharmD, Katherine Robbins Ph.D.
9:45 - 10:30
Networking Breakout Session
BIO Business Solutions Networking Session
Speakers:
Bob Dearth, Brian Haigh, Jake Rubritz, Lori Cotsack, Stephen Joseph
Michael Fleming
Michael Fleming
President
Delaware BioScience Association
Benjamin Quang Duong PharmD
Benjamin Quang Duong PharmD
Clinical Pharmacogenomics Service Manager
Dr. Benjamin Duong is the Clinical Pharmacogenomics Service Manager under the Nemours Precision Medicine Program at Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. He leads the implementation of a pharmacogenomics service across the Nemours Children Health System enterprise with hospitals and clinics in Delaware, Florida, Maryland, Pennsylvania, and New Jersey. He received his Doctorate of Pharmacy in 2016 and completed a Clinical Pharmacogenomics pharmacy residency in 2018 from the University Of Florida College Of Pharmacy in Gainesville, FL. His focus includes implementation of a pharmacogenetic testing service that will improve the wellbeing of pediatric patients through increased pharmacotherapy clinical effectiveness while minimizing adverse drug reactions associated with genetic variants. His implementation of pharmacogenomics includes developing pharmacogenetic tests, integrating pharmacogenetic clinical decision support into the electronic medical records, providing clinical recommendations with internal and external pharmacogenomic results, and educating patients and health care professionals.
Katherine Robbins Ph.D.
Katherine Robbins Ph.D.
Director, Nemours Biomolecular Core Lab
Dr. Katherine Robbins is the director of the Nemours Biomolecular Core Laboratory, that provides essential services in molecular biology and genetics to the clinical and research staff at Nemours, Delaware INBRE partner institutions, and external clients. The Biomolecular Core Laboratory provides consultation on experimental design as well as data troubleshooting, training, and mentoring of students and clinical fellows. The BCL is also a collaborative research laboratory focusing on the study of rare pediatric genetic disorders. She received her doctorate in Biological Sciences from University of Delaware in 2016 and her continued interest is primarily associated with rasopathies, skeletal dysplasias and cancer. In addition, she is Assistant research scientist in the Nemours Molecular Diagnostics Laboratory, where she helps implement new diagnostic testing and assays. She works closely in a team-science based approach with clinicians, pharmacists, researchers, patient and family groups to bring the necessary testing needed to Nemours. Most recently, the Molecular Diagnostics and Biomolecular Core labs have worked closely with Dr. Benjamin Duong, PharmD Clinical Pharmacogenomics Service Manager, and the Nemours Precision Medicine Program to develop a pharmacogenomics 10 gene assay that has been implemented in both clinical and research settings at Nemours.
Janet Reed Ph.D.
Janet Reed Ph.D.
Partner
Dr. Janet E. Reed is the head of the firm’s intellectual property transactional and counseling practice. Though she counsels in all aspects of intellectual property, Janet focuses her practice on patents related to biotechnological inventions in food, medicine and agriculture. Her clients span a variety of industries and include large and small pharmaceutical and biotechnology companies, agricultural and food companies, and academic institutions. Janet has extensive experience in domestic and foreign patent prosecution, patent portfolio management and strategic planning, evaluation of new technology, drafting of license and other commercialization agreements, conducting and responding to due diligence inquiries, and preparation of opinions on patentability, infringement and freedom to operate. In addition to her law degree, Janet holds a Ph.D. in biochemistry and a Master’s degree in plant pathology. Prior to entering patent law, Janet accumulated ten years of laboratory experience in biochemistry, molecular biology and plant physiology/pathology, in graduate-level research and as a visiting postdoctoral research scientist at DuPont. Publications Publishing and Patenting the Fruits of Academic Research: the Key to a Successful Parallel Track Nature Immunology, May 20, 2013 Capitalizing on Innovation: The Fundamentals of Intellectual Property Delaware Banker, November 1, 2011
Bob Dearth
Bob Dearth
Regional Business Development Manager, BIO Business Solutions
Biotechnology Innovation Organization (BIO)
Stephen Joseph
Stephen Joseph
BREX
Lori Cotsack
Lori Cotsack
Senior Account Manager
Clean Harbors
Brian Haigh
Brian Haigh
Region Director, Sales
VWR, Part of Avantor
Jake Rubritz
Jake Rubritz
Account Manager
VWR, Part of Avantor

Book Event

Member FREE
Available Tickets: Unlimited
The Member ticket is sold out. You can try another ticket or another date.
Non Member $50
Available Tickets: Unlimited
The Non Member ticket is sold out. You can try another ticket or another date.
In Transition $25
Available Tickets: Unlimited
The In Transition ticket is sold out. You can try another ticket or another date.